Tag: Cancer: Prostate
Tall, Obese Men at Higher Risk of Aggressive Prostate Cancer
Study found taller, heavier males were more likely to develop prostate cancer, die from it
Decisional Regret Doesn’t Differ by Treatment in Prostate Cancer
Only African-American race was associated with greater regret across time
Germline Mutations Up in Men With Prostate CA, One Other CA
However, most of these men do not meet current clinical criteria for germline testing
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
Novel Biomarkers Identified for Prostate Cancer in Non-Blacks
PCA3 and T2ERG add utility for predicting prostate cancer when combined with PCPT risk calculator
ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
Substantial Increase in Costs With Metastases in Prostate CA
Costs peak during month of metastases diagnosis, reaching $13,291
Combined Urine Test for T2:ERG, PCA3 Ups Prostate CA Detection
Combined urinary testing can avoid unnecessary prostate biopsy, while preserving high sensitivity
Distinct Outcomes for Luminal-, Basal-Like Prostate Cancers
Luminal B prostate cancers exhibited poorest clinical prognosis in univariate, multivariate analyses
Black Men Have Higher Rate of Preclinical Prostate Cancer
Also increased risk of progression to metastatic disease compared with the general population
